The real problem with the Guvera IPO 

The float has been controversial, but there's a bigger issue. 

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Before this week, you almost certainly had never heard of Guvera. And to the extent that it's become more broadly known over the last seven days, it's for all of wrong reasons — at least from the company's perspective.

You see, Guvera, an online music streaming service, is looking to go public, with a valuation of up to $1.3 billion. For a company that last year had $1.2 million in sales. And lost money — over $81 million in the last 12 months. That's a tall order.

The company came to prominence in no small part thanks to strong comments from a couple of tech pioneers. Atlassian co-founder Mike Cannon-Brookes is quoted as calling the IPO 'terrifying'. And Seek co-founder and venture capitalist Paul Bassat tweeted:

"The quality, readiness and valuation of some of the tech companies coming to market is an absolute disgrace"

The comments from Bassat and Cannon-Brookes have been widely reported and commented on.

And, seemingly stung into action (though it's always possible these things were already underway) ASIC and the ASX have — temporarily, for now — postponed the float.

What's wrong with Guvera?

The criticisms of Guvera are many. That the private equity backers are related parties of one of the company's officers. That it's losing money (and has precious little revenue). And that without the float proceeds, the company would struggle to continue operating. Plus more.

Those observations are all true. And while I respect the success of both of the tech titans quoted above, and I agree with their assessment of the risks of investing in Guvera, I don't think the company should be precluded from listing on the ASX.

After all, it'll hardly be the only company on the exchange that is losing money. Or that will need to raise more capital to stay in business. Or whose executives have potential conflicts of interest.

Picking on Guvera, no matter how worthy the criticism, has the effect of sending the message "the market is working properly, except for this particular company".

And in acting to review Guvera, the regulator and market operator are giving the impression of action (because, in fairness, they actually are), but Guvera's fate will only address a symptom of the broader problem — not the problem itself.

Which is?

The elephant in the room

Far less reported was Paul Bassat's second tweet, immediately after the one quoted above.

Tell 'em what you said, Paul:

"Some advisers and entrepreneurs will make a killing but it will be a zero sum game and retail investors will be the losers."

And that's the real issue.

Indeed, the AFR reported last week:

"In some instances accountants, who received kick-backs, helped clients set up self-managed super funds to invest in Guvera in circumstances allowed under a regulatory loophole due to close from July 1, 2016."

Frankly, if Guvera has been honest in its prospectus, and the company meets listing rules, it should be allowed to join the ASX. If investors are aware — truly aware — of the very, very significant risks involved in buying shares, neither ASIC nor the ASX.

If there's something wrong with Guvera's prospectus, the float should be postponed until it's fixed.

If there's something wrong with unprofitable businesses listing on the ASX, then we should remove hundreds of unprofitable businesses already trading on the bourse. (And for the record, of the 1900-odd companies listed on the ASX, less than 700 turned in a profit over the last 12 months.)

But if the problem is with the incentives of those in the financial planning world, then stopping Guvera from listing presents the facade of doing something about a problem without actually doing it. It'd be window-dressing, pure and simple.

Foolish takeaway

Retail investors deserve protection from those who would take advantage of them. Perhaps Guvera is among that number, but the bigger problem is below the surface — and those who are taking advantage of retail investors will still be in business next week, whether Guvera floats or not.

Motley Fool contributor Scott Phillips (TMFGilla) has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »